Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on 4basebio PLC. We currently have 23 research reports from 2 professional analysts.
- Open: 1045p
- Range Today: 0.00/0.00p
- 52 Week: 492/1070p
- Daily Volume: 0.0k
- Daily Liquidity: 0%
- # Shares: 12.8m
- Market Cap: 133.8m
- Latest PE (hist):
- Div Yield:
Date | Source | Announcement |
---|---|---|
10Apr24 07:00 | PRN | 4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program |
21Mar24 07:00 | PRN | 4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine |
01Mar24 07:00 | PRN | 4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence |
06Feb24 07:01 | PRN | 4basebio Plc - Holding(s) in Company |
06Feb24 07:01 | PRN | 4basebio Plc - Holding(s) in Company |
06Feb24 07:01 | PRN | 4basebio Plc - Holding(s) in Company |
06Feb24 07:01 | PRN | 4basebio Plc - Holding(s) in Company |
Share: